{
  "id": 6573502,
  "title": "Hong Kong watchdog investigates Cloudbreak Pharma for ‘rigged’ IPO, suspends its shares",
  "url": "https://urgent.news/2026/09/10/hong-kong-watchdog-investigates-cloudbreak-pharma-for-rigged-ipo-6573502",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-10T10:08:13.000Z",
  "source": {
    "name": "South China Morning Post",
    "slug": "south-china-morning-post",
    "url": "https://www.scmp.com/business/banking-finance/article/3367064/hong-kong-watchdog-investigates-cloudbreak-pharma-rigged-ipo-suspends-its-shares"
  },
  "original_language": "en",
  "account": "Hong Kong's Securities and Futures Commission (SFC) has initiated an investigation into biotechnology firm Cloudbreak Pharma following allegations of a \"rigged\" IPO. The SFC has directed the Hong Kong stock exchange to suspend trading of the company's shares, citing concerns that the IPO may have been manipulated to create an artificial demand for its shares. This action is aimed at maintaining an orderly and fair market and protecting the interests of investors. Cloudbreak Pharma, which focused on developing treatments for eye diseases, raised HK$611.88 million (US$78.45 million) in its IPO, with the retail portion being oversubscribed 77 times. However, the company's share price plummeted 39% on the first day of trading, and it has since lost over 90% of its IPO value. The shares were suspended at 9am on the day of the suspension announcement. Cloudbreak Pharma's founder and CEO, Ni Jinsong, had previously worked for pharmaceutical giants Pfizer and Allergan before establishing the company in California in 2015. The firm's IPO, which was conducted under Hong Kong's Chapter 18A rules designed for pre-revenue biotech companies, raised significant funds for the sector.",
  "summary": "Hong Kong’s Securities and Futures Commission (SFC) has directed the stock exchange to suspend trading of US-based biotech firm Cloudbreak Pharma pending an investigation into its US$78 million initial public offering (IPO) last year. “The SFC has serious concerns that Cloudbreak’s initial public offering may have been rigged to create an artificial impression of demand for Cloudbreak’s shares,”…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 5,
    "also_reported_by": [
      {
        "outlet": "SCMP Business",
        "title": "Hong Kong landlords accuse banks of deepening shop slump with reluctance to lend",
        "url": "https://urgent.news/2026/09/07/hong-kong-landlords-accuse-banks-of-deepening-shop-slump-with",
        "published": "2026-09-07T11:00:09.000Z"
      },
      {
        "outlet": "Financial Times",
        "title": "Tung Chee-hwa, Hong Kong chief executive, 1937-2026",
        "url": "https://urgent.news/2026/09/08/tung-chee-hwa-hong-kong-chief-executive-1937-2026",
        "published": "2026-09-08T19:14:13.000Z"
      },
      {
        "outlet": "The Business Times - Companies & Markets",
        "title": "Top Hong Kong developer’s profit increases on market recovery",
        "url": "https://urgent.news/2026/09/10/top-hong-kong-developers-profit-increases-on-market-recovery",
        "published": "2026-09-10T12:05:36.000Z"
      },
      {
        "outlet": "Finextra",
        "title": "Unlimit expands its Asia-Pacific presence with Hong Kong money service operator licence",
        "url": "https://urgent.news/2026/09/11/unlimit-expands-its-asia-pacific-presence-with-hong-kong-money",
        "published": "2026-09-11T09:59:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}